Edwards Lifesciences Corporation logo

Edwards Lifesciences Corporation

EW | NYSE
Chart Builder DCF Calculator
$92.01
-$2.43 (-2.57%)
At close: Oct 30, 2026, 4:00 PM ET
$92.61
+$0.60 (+0.65%)
Pre-market: Nov 2, 2026, 7:00 AM ET
Fiscal Year
Period Ending
FY 2025
Dec 31, 2025
FY 2024
Dec 31, 2024
FY 2023
Dec 31, 2023
FY 2022
Dec 31, 2022
FY 2021
Dec 31, 2021
FY 2020
Dec 31, 2020
Net Income
1.07B 4.17B 1.4B 1.52B 1.5B 823.4M
Depreciation & Amortization
156.6M 155.2M 144.9M 139.6M 134.8M 107.2M
Stock-Based Compensation
158.1M 162.3M 139.4M 126.8M 109.3M 92.6M
Other Working Capital
-268.2M -213.9M -242.1M -102.5M 43.5M -36.6M
Other Non-Cash Items
174.1M -3.36B 7.5M 105.8M -119M 38.3M
Deferred Income Tax
-117.6M -323.4M -272.1M -254.5M -41.4M -49.4M
Change in Working Capital
154.6M -259.3M -526.3M -421.4M 145.3M 42.2M
Operating Cash Flow
1.6B 542.3M 895.8M 1.22B 1.73B 1.05B
Capital Expenditures
-260.2M -252.4M -266.3M -264.8M -329.8M -407.3M
Cash Acquisitions
n/a -1.06B -95.2M n/a 329.8M 407.3M
Purchase of Investments
-3.14B -945.8M -105.5M -778.9M -1.89B -861.7M
Sales Maturities Of Investments
2.88B 857.6M 715.8M 1.36B 529.2M 777M
Other Investing Acitivies
-195.7M 3.75B -75M -63.1M -359.3M -446.4M
Investing Cash Flow
-712.9M 2.31B 173.8M 252.3M -1.72B -531.1M
Debt Repayment
n/a n/a -300K -200K -1.8M -800K
Common Stock Repurchased
-893.4M -1.16B -879.6M -1.73B -512.8M -625.4M
Dividend Paid
n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-237.5M 176.4M 168.9M 142.8M 158.3M 139.3M
Financial Cash Flow
-956.8M -983M -711M -1.58B -356.3M -486.9M
Net Cash Flow
-119.3M 1.91B 375.4M -94.8M -332.8M 15.8M
Free Cash Flow
1.34B 289.9M 629.5M 953.4M 1.4B 647M
Adj. Free Cash Flow
1.18B 127.6M 490.1M 826.6M 1.29B 554.4M
Maintenance CapEx
-61.12M -120.17M -266.3M -223.5M -110.85M -398.11M
Growth CapEx
-199.08M -132.23M n/a -41.3M -218.95M -9.19M
Owner Earnings
1.53B 422.13M 629.5M 994.7M 1.62B 656.19M

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.